FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308842006> ?p ?o ?g. }

• W4308842006 abstract "Abstract Background The availability of new immuno-oncology therapeutics markedly impacts oncology clinicians’ treatment decision-making. To effectively support healthcare professionals (HCPs) in their practice, it is important to better understand the challenges and barriers that can accompany the introduction of these agents. This study aimed to establish the types and causes of clinical challenges posed by the introduction of new immuno-oncology agents. Methods The mixed-methods design included qualitative in-depth interviews and group discussions with HCPs, in which participants discussed clinical challenges and potential underlying reasons for these challenges. Qualitative findings informed a quantitative survey. This survey investigated the extent and distribution of challenges using HCPs’ self-rating of knowledge, skill, confidence, and exposure to system-level effects. These two phases were conducted sequentially with distinctly stratified samples of oncologists, nurse practitioners (NPs), physician assistants (PAs), pathologists, clinical pharmacists, interventional radiologists, rheumatologists, pulmonologists, and emergency department physicians. Participants were from the United States and had various levels of clinical experience and represented both academic and community-based settings. Results The final sample included 107 HCPs in the qualitative phase and 554 in the quantitative phase. Analyses revealed clinical challenges related to the use of pharmacodiagnostics. For example, 47% of pathologists and 42% of oncologists reported skill gaps in identifying the appropriate marker and 46% of oncologists, 61% of PAs, 66% of NPs, 74% of pulmonologists and 81% of clinical pharmacists reported skill gaps in selecting treatment based on test results. Challenges also emerged regarding the integration of immuno-oncology agents, as oncologists, rheumatologists, pulmonologists, clinical pharmacists, PAs, and NPs reported knowledge gaps (74-81%) of the safety profiles of recently approved agents. In addition, 90% of clinical pharmacists reported skill gaps weighing the risks and benefits of treating patients with immuno-oncology agents while affected by lupus. Finally, patient communication challenges were identified: HCPs reported difficulties discussing essential aspects of immunotherapy to patients as well as how they might compare to other types of therapies. Conclusion The challenges highlighted in this study reveal substantial educational gaps related to the integration of immuno-oncology agents into practice for various groups of HCPs. These findings provide a strong base of evidence for future educational initiatives." @default.
• W4308842006 created "2022-11-17" @default.
• W4308842006 creator A5000159448 @default.
• W4308842006 creator A5002293304 @default.
• W4308842006 creator A5004987540 @default.
• W4308842006 creator A5033464248 @default.
• W4308842006 creator A5034115525 @default.
• W4308842006 creator A5038165740 @default.
• W4308842006 creator A5049241351 @default.
• W4308842006 creator A5079438136 @default.
• W4308842006 creator A5088574808 @default.
• W4308842006 date "2022-11-12" @default.
• W4308842006 modified "2023-09-25" @default.
• W4308842006 title "Challenges associated with the integration of immuno-oncology agents in clinical practice" @default.
• W4308842006 cites W1969563312 @default.
• W4308842006 cites W1972825759 @default.
• W4308842006 cites W2085028749 @default.
• W4308842006 cites W2105322770 @default.
• W4308842006 cites W2142225512 @default.
• W4308842006 cites W2224030228 @default.
• W4308842006 cites W2346275821 @default.
• W4308842006 cites W2493050340 @default.
• W4308842006 cites W2497919442 @default.
• W4308842006 cites W2680541203 @default.
• W4308842006 cites W2736477263 @default.
• W4308842006 cites W2752561188 @default.
• W4308842006 cites W2755024608 @default.
• W4308842006 cites W2770799637 @default.
• W4308842006 cites W2806838035 @default.
• W4308842006 cites W2808404999 @default.
• W4308842006 cites W2885851963 @default.
• W4308842006 cites W2905473249 @default.
• W4308842006 cites W2911334948 @default.
• W4308842006 cites W2921361224 @default.
• W4308842006 cites W2941175744 @default.
• W4308842006 cites W2941844619 @default.
• W4308842006 cites W2947756905 @default.
• W4308842006 cites W2950836608 @default.
• W4308842006 cites W2951189947 @default.
• W4308842006 cites W2970886433 @default.
• W4308842006 cites W3000339487 @default.
• W4308842006 cites W3004003013 @default.
• W4308842006 cites W3013949914 @default.
• W4308842006 cites W3037345585 @default.
• W4308842006 cites W3043466521 @default.
• W4308842006 cites W3044891065 @default.
• W4308842006 cites W3108129662 @default.
• W4308842006 cites W3119364376 @default.
• W4308842006 cites W3209552579 @default.
• W4308842006 cites W3214623580 @default.
• W4308842006 doi "https://doi.org/10.1186/s12909-022-03847-0" @default.
• W4308842006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36371179" @default.
• W4308842006 hasPublicationYear "2022" @default.
• W4308842006 type Work @default.
• W4308842006 citedByCount "0" @default.
• W4308842006 crossrefType "journal-article" @default.
• W4308842006 hasAuthorship W4308842006A5000159448 @default.
• W4308842006 hasAuthorship W4308842006A5002293304 @default.
• W4308842006 hasAuthorship W4308842006A5004987540 @default.
• W4308842006 hasAuthorship W4308842006A5033464248 @default.
• W4308842006 hasAuthorship W4308842006A5034115525 @default.
• W4308842006 hasAuthorship W4308842006A5038165740 @default.
• W4308842006 hasAuthorship W4308842006A5049241351 @default.
• W4308842006 hasAuthorship W4308842006A5079438136 @default.
• W4308842006 hasAuthorship W4308842006A5088574808 @default.
• W4308842006 hasBestOaLocation W43088420061 @default.
• W4308842006 hasConcept C113616995 @default.
• W4308842006 hasConcept C114200698 @default.
• W4308842006 hasConcept C126322002 @default.
• W4308842006 hasConcept C143998085 @default.
• W4308842006 hasConcept C144024400 @default.
• W4308842006 hasConcept C17744445 @default.
• W4308842006 hasConcept C177713679 @default.
• W4308842006 hasConcept C190248442 @default.
• W4308842006 hasConcept C199539241 @default.
• W4308842006 hasConcept C2779473830 @default.
• W4308842006 hasConcept C2908861384 @default.
• W4308842006 hasConcept C36289849 @default.
• W4308842006 hasConcept C509550671 @default.
• W4308842006 hasConcept C512399662 @default.
• W4308842006 hasConcept C71924100 @default.
• W4308842006 hasConceptScore W4308842006C113616995 @default.
• W4308842006 hasConceptScore W4308842006C114200698 @default.
• W4308842006 hasConceptScore W4308842006C126322002 @default.
• W4308842006 hasConceptScore W4308842006C143998085 @default.
• W4308842006 hasConceptScore W4308842006C144024400 @default.
• W4308842006 hasConceptScore W4308842006C17744445 @default.
• W4308842006 hasConceptScore W4308842006C177713679 @default.
• W4308842006 hasConceptScore W4308842006C190248442 @default.
• W4308842006 hasConceptScore W4308842006C199539241 @default.
• W4308842006 hasConceptScore W4308842006C2779473830 @default.
• W4308842006 hasConceptScore W4308842006C2908861384 @default.
• W4308842006 hasConceptScore W4308842006C36289849 @default.
• W4308842006 hasConceptScore W4308842006C509550671 @default.
• W4308842006 hasConceptScore W4308842006C512399662 @default.
• W4308842006 hasConceptScore W4308842006C71924100 @default.
• W4308842006 hasIssue "1" @default.
• W4308842006 hasLocation W43088420061 @default.
• W4308842006 hasLocation W43088420062 @default.
• W4308842006 hasLocation W43088420063 @default.

• next